{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:03:28Z","timestamp":1773291808541,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.amjcard.2008.02.026","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T12:10:21Z","timestamp":1207138221000},"page":"S3-S8","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S","title":["Safety of Niacin and Simvastatin Combination Therapy"],"prefix":"10.1016","volume":"101","clinical-trial-number":[{"clinical-trial-number":"nct00080275","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00082251","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00269217","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00479882","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Harold","family":"Bays","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2008.02.026_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/14779072.2.4.485","article-title":"Extended-release niacin\/lovastatin: the first combination product for dyslipidemia","volume":"2","author":"Bays","year":"2004","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjcard.2008.02.026_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11140","article-title":"A systematic review and economic evaluation of statins for the prevention of coronary events","volume":"11","author":"Ward","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.amjcard.2008.02.026_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch Intern Med"},{"issue":"suppl","key":"10.1016\/j.amjcard.2008.02.026_bib6","doi-asserted-by":"crossref","first-page":"6C","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: an overview and assessment of the data\u20142005","volume":"97","author":"Bays","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.163.5.553","article-title":"Risk for myopathy with statin therapy in high-risk patients","volume":"163","author":"Ballantyne","year":"2003","journal-title":"Arch Intern Med"},{"issue":"suppl","key":"10.1016\/j.amjcard.2008.02.026_bib8","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib10","series-title":"Dosage and titration patterns of extended-release niacin in clinical practice","author":"Kamal-Bahl","year":"2006"},{"key":"10.1016\/j.amjcard.2008.02.026_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9149(03)00007-9","article-title":"Comparison of once-daily, niacin extended-release\/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE])","volume":"91","author":"Bays","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjcard.2003.10.009","article-title":"Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (the HDL Atherosclerosis Treatment Study)","volume":"93","author":"Zhao","year":"2004","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2008.02.026_bib13","doi-asserted-by":"crossref","first-page":"30K","DOI":"10.1016\/S0002-9149(02)02971-5","article-title":"Existing and investigational combination drug therapy for high-density lipoprotein cholesterol","volume":"90","author":"Bays","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjcard.2004.09.013","article-title":"Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)","volume":"95","author":"Canner","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebcm.2004.03.032","article-title":"Commentary: trial finds that simvastatin plus niacin is safe in people with coronary artery disease and low HDL cholesterol","volume":"8","author":"Bays","year":"2004","journal-title":"Evid Based Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2008.02.026_bib16","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1001\/jama.1990.03450230043027","article-title":"Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens","volume":"264","author":"Kane","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2008.02.026_bib17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1185\/030079907X210525","article-title":"Rationale and design of a prospective clinical trial program to evaluate colesevelam\u2019s glucose-lowering effects in patients with type 2 diabetes mellitus","volume":"23","author":"Bays","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2008.02.026_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MJT.0b013e31815a69fc","article-title":"The \u201cforgotten\u201d bile acid sequestrants: is now a good time to remember?","volume":"14","author":"Bays","year":"2007","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2008.02.026_bib19","first-page":"1","article-title":"Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors","volume":"3","author":"Bays","year":"2007","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.amjcard.2008.02.026_bib20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.02.026_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0895-7061(02)03196-5","article-title":"Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects","volume":"16","author":"Gadegbeku","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjcard.2008.02.026_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2008.02.026_bib23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2008.02.026_bib24","unstructured":"Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin and simvastatin monotherapy: the SEACOST I (high-dose) study. Am J Cardiol. In Press."},{"key":"10.1016\/j.amjcard.2008.02.026_bib25","doi-asserted-by":"crossref","unstructured":"Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH. Comparison of the efficacy and safety of a combination tablet of niacin extended-release and simvastatin with simvastatin 80 mg monotherapy: the SEACOST II (high-dose) study. J Clin Lipidol. In press.","DOI":"10.1016\/j.jacl.2008.02.004"},{"key":"10.1016\/j.amjcard.2008.02.026_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00129784-200808020-00001","article-title":"Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study","volume":"2","author":"Karas","year":"2008","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914908002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T10:58:15Z","timestamp":1546167495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914908002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0002914908002506"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2008.02.026","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}